Search research articles
Contact Us
Filters
Showing results (671-680 of 1,192) with videos related to
Page
of 120
Sort By:
Leukemia Research
|
August 2, 2006
Cytokine and chemokine profiles in multiple myeloma; significance of stromal interaction and correlation of IL-8 production with disease progression
Michael Kline, Kathleen Donovan, Linda Wellik, et al.
Current Alzheimer Research
|
July 18, 2006
The pharmacology of aminoadamantane nitrates
Yuqiang Wang, Jerry Eu, Mark Washburn, et al.
Clinical Lymphoma & Myeloma
|
October 10, 2006
Response to rituximab in patients with type II cryoglobulinemia
Alan H Bryce, Angela Dispenzieri, Robert A Kyle, et al.
American Journal of Hematology
|
December 23, 2011
Sorafenib, a multikinase inhibitor, is effective in vitro against non-Hodgkin lymphoma and synergizes with the mTOR inhibitor rapamycin
Vijay Ramakrishnan, Michael Timm, Jessica L Haug, et al.
The New England Journal of Medicine
|
March 31, 2006
Prevalence of monoclonal gammopathy of undetermined significance
Robert A Kyle, Terry M Therneau, S Vincent Rajkumar, et al.
The Journal of Biological Chemistry
|
July 26, 2019
The cellular regulators PTEN and BMI1 help mediate NEUROGENIN-3-induced cell cycle arrest
R Sergio Solorzano-Vargas, Matthew Bjerknes, S Vincent Wu, et al.
Military Medicine
|
April 7, 2012
Effects of military deployment on cognitive functioning
Andrea S Vincent, Tresa Roebuck-Spencer, Mary S Lopez, et al.
European Heart Journal
|
March 23, 2017
Sex hormones affect outcome in arrhythmogenic right ventricular cardiomyopathy/dysplasia: from a stem cell derived cardiomyocyte-based model to clinical biomarkers of disease outcome
Deniz Akdis, Ardan M Saguner, Khooshbu Shah, et al.
American Journal of Hematology
|
May 15, 2024
Three-dimensional telomere profiling predicts risk of progression in smoldering multiple myeloma
Shaji Kumar, S Vincent Rajkumar, Dragan Jevremovic, et al.
European Journal of Haematology
|
February 19, 2015
Clinical Course and Prognosis of Non-Secretory Multiple Myeloma
Sagar S Chawla, Shaji K Kumar, Angela Dispenzieri, et al.
Page
of 120
Search research articles
Search
Showing results (671-680 of 1,192) with videos related to
Sort By:
Page
of 120
Leukemia Research
|
August 2, 2006
Cytokine and chemokine profiles in multiple myeloma; significance of stromal interaction and correlation of IL-8 production with disease progression
Michael Kline, Kathleen Donovan, Linda Wellik, et al.
Current Alzheimer Research
|
July 18, 2006
The pharmacology of aminoadamantane nitrates
Yuqiang Wang, Jerry Eu, Mark Washburn, et al.
Clinical Lymphoma & Myeloma
|
October 10, 2006
Response to rituximab in patients with type II cryoglobulinemia
Alan H Bryce, Angela Dispenzieri, Robert A Kyle, et al.
American Journal of Hematology
|
December 23, 2011
Sorafenib, a multikinase inhibitor, is effective in vitro against non-Hodgkin lymphoma and synergizes with the mTOR inhibitor rapamycin
Vijay Ramakrishnan, Michael Timm, Jessica L Haug, et al.
The New England Journal of Medicine
|
March 31, 2006
Prevalence of monoclonal gammopathy of undetermined significance
Robert A Kyle, Terry M Therneau, S Vincent Rajkumar, et al.
The Journal of Biological Chemistry
|
July 26, 2019
The cellular regulators PTEN and BMI1 help mediate NEUROGENIN-3-induced cell cycle arrest
R Sergio Solorzano-Vargas, Matthew Bjerknes, S Vincent Wu, et al.
Military Medicine
|
April 7, 2012
Effects of military deployment on cognitive functioning
Andrea S Vincent, Tresa Roebuck-Spencer, Mary S Lopez, et al.
European Heart Journal
|
March 23, 2017
Sex hormones affect outcome in arrhythmogenic right ventricular cardiomyopathy/dysplasia: from a stem cell derived cardiomyocyte-based model to clinical biomarkers of disease outcome
Deniz Akdis, Ardan M Saguner, Khooshbu Shah, et al.
American Journal of Hematology
|
May 15, 2024
Three-dimensional telomere profiling predicts risk of progression in smoldering multiple myeloma
Shaji Kumar, S Vincent Rajkumar, Dragan Jevremovic, et al.
European Journal of Haematology
|
February 19, 2015
Clinical Course and Prognosis of Non-Secretory Multiple Myeloma
Sagar S Chawla, Shaji K Kumar, Angela Dispenzieri, et al.
Page
of 120